You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage IV urethral cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Change in Mood, Change in Personality Trial in Haskovo (Undenatured beta-glucan solution, Placebo)

Recruiting
  • Change in Mood
  • Change in Personality
  • Undenatured beta-glucan solution
  • Placebo
  • Haskovo, Bulgaria
    CLINECA EAD Hospital
Jul 18, 2023

HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle

Active, not recruiting
  • HER2-positive Breast Cancer
  • +8 more
  • pNGVL3-hICD vaccine
  • +6 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Cetuximab
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 2, 2023

Quality of Life and Utilities Following Surgical Treatment of

Recruiting
  • Rectal Adenocarcinoma
  • +13 more
  • Quality-of-Life Assessment
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Oct 11, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Shanghai (Endostar,

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 17, 2023

Breast Cancer, Insomnia Trial (transauricular Vagus Nerve Stimulation)

Not yet recruiting
  • Breast Cancer
  • Insomnia
  • transauricular Vagus Nerve Stimulation
  • (no location specified)
Aug 21, 2023

Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial (Cisplatin, No treatment)

Not yet recruiting
  • Stage III Ovarian Cancer
  • +5 more
  • (no location specified)
Dec 12, 2022

Double-dose Furmonertinib in Treatment of Slow

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • (no location specified)
Oct 31, 2023

Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in

Completed
Has Results
  • Distal Urethral Cancer
  • +10 more
  • Gemcitabine hydrochloride
  • +3 more
  • Springfield, Missouri
  • +1 more
Sep 17, 2020

Stage IV NSCLC Trial in Wuhan (SBRT+Osimertinib, Osimertinib 80 MG)

Not yet recruiting
  • Stage IV Non-small Cell Lung Cancer
  • SBRT+Osimertinib
  • Osimertinib 80 MG
  • Wuhan, Hubei, China
    Tongji Hospital Affiliated to Tongji Medical College of Huazhong
Oct 13, 2022

Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and

Recruiting
  • Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
  • +4 more
  • Cemiplimab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 17, 2023

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (Chemotherapy, Pembrolizumab, Ramucirumab)

Not yet recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • (no location specified)
Jan 9, 2023

Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication

Completed
Has Results
  • Caregiver
  • +37 more
  • Communication Intervention
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 14, 2022

NSCLC Without Mutation in Epidermal Growth Factor Receptor (Disorder) Trial (tereotactic body radiotherapy)

Not yet recruiting
  • Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)
  • tereotactic body radiotherapy
  • (no location specified)
Dec 1, 2023

Metastatic Malignant Tumor in the Bone, Stage IV Breast Cancer AJCC v6 and v7, Triple-Negative Breast Carcinoma Trial in

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Bone
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 4, 2023

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +22 more
  • Laboratory Biomarker Analysis
  • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Oct 7, 2022

Breast Cancer Stage IV Trial in Irvine (Gallium-68)

Recruiting
  • Breast Cancer Stage IV
  • Irvine, California
    Hoag Memorial Hospital Presbyterian
May 26, 2023

Ovarian Cancer Trial (Huaier granule)

Not yet recruiting
  • Ovarian Cancer
  • Huaier granule
  • (no location specified)
Feb 28, 2023

Anal Melanoma, Bladder Melanoma, Cervical Melanoma Trial in United States (Cabozantinib S-malate, Nivolumab, Placebo

Recruiting
  • Anal Melanoma
  • +18 more
  • Cabozantinib S-malate
  • +5 more
  • Los Angeles, California
  • +53 more
Jan 31, 2023

Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Sacramento

Recruiting
  • Advanced Colorectal Carcinoma
  • +15 more
  • Fermented Wheat Germ Extract
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jul 26, 2023

Stage IV Lung Adenocarcinoma Trial in United States (Certolizumab, cisplatin, pemetrexed)

Completed
  • Stage IV Lung Adenocarcinoma
  • Basking Ridge, New Jersey
  • +5 more
Jan 25, 2023

Caregiver, Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial in Houston (Educational Intervention,

Recruiting
  • Esophageal Carcinoma
  • +16 more
  • Educational Intervention
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 11, 2022

Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

Active, not recruiting
  • Stage III Fallopian Tube Cancer AJCC v7
  • +14 more
  • Houston, Texas
  • +4 more
Oct 20, 2022

Non Small Cell Lung Cancer Trial in Shanghai (CS1001 mAb, CS1001 )

Active, not recruiting
  • Non Small Cell Lung Cancer
  • CS1001 monoclonal antibody
  • CS1001 placebo
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Nov 8, 2022

Stage III Vulvar Cancer, Stage III Ovarian Cancer, Stage III Uterine Cancer Trial in Indianapolis (Intervention group triads)

Enrolling by invitation
  • Stage III Vulvar Cancer
  • +7 more
  • Intervention group triads
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
Aug 10, 2023